Yayınlar

The evolution of comprehensive genetic analysis in neurology: Implications for precision medicine

Eirini Papadopoulou a,* , Georgia Pepe a , Spiridon Konitsiotis b , Maria Chondrogiorgi b , Nikolaos Grigoriadis c , Vasilios K. Kimiskidis d , Georgios Tsivgoulis e , Dimos D. Mitsikostasf , Elisabeth Chroni g , Eleni Domouzoglou h , Georgios Tsaousis a , Georgios Nasioulas a

Journal of the Neurological Sciences

CNV and RNA analysis reveal a germline pathogenic duplication of MSH2 exon 15 in a family with Lynch syndrome: A case report

Despina Apostolopoulou1 ; Mustafa Özdoğan2 ; Konstantinos Agiannitopoulos1 *; Georgia Pepe1 ; Kevisa Potska1 ; Georgios N Tsaousis1 ; Nikolaos Tsoulos1 ; Eleni Patsea3 ; Onder Kırca2 ; Muharrem Okan Çakır4 ; Eirini Papadopoulou1 ; George Nasioulas1

JCIMCR-v4-2289

Importance of multigene panel test in patients with consanguineous marriage and family history of breast cancer

Vahit Ozmen, Ahmet Okay Caglayan, Kanay Yararbas, Cetin Ordu, Fatma Aktepe, Tolga Ozmen, Ahmet Serkan Ilgun, Gursel Soybir, Gul Alco, Georgios N Tsaousis, Eirini Papadopoulou, Konstantinos Agiannitopoulos, Georgia Pepe, Stavroula Kampouri, George Nasioulas, Efe Sezgin, Atilla Soran

Ozmen et al

Revisiting the Implications of Positive Germline Testing Results Using Multi-gene Panels in Breast Cancer Patients

Georgios N Tsaousis, Eirini Papadopoulou, Konstantinos Agiannitopoulos, Georgia Pepe, Nikolaos Tsoulos, Ioannis Boukovinas, Theofanis Floros, Rodoniki Iosifidou, Ourania Katopodi, Anna Koumarianou, Christos Markopoulos, Konstantinos Papazisis, Vasileios Venizelos, Achilleas Kapsimalis, Grigorios Xepapadakis, Amanda Psyrri, Eugeniu Banu, Dan Tudor Eniu, Alexandru Blidaru, Dana Lucia Stanculeanu, Andrei Ungureanu, Vahit Ozmen, Sualp Tansan, Mehmet Tekinel, Suayib Yalcin, George Nasioulas

Tsaousis_et_al_2022

Comprehensive tumor molecular profile analysis in clinical practice

Mustafa Özdoğan, Eirini Papadopoulou, corresponding author Nikolaos Tsoulos, Aikaterini Tsantikidi, Vasiliki-Metaxa Mariatou,Georgios Tsaousis, Evgenia Kapeni, Evgenia Bourkoula, Dimitrios Fotiou, Georgios Kapetsis, Ioannis Boukovinas, Nikolaos Touroutoglou, Athanasios Fassas, Achilleas Adamidis, Paraskevas Kosmidis, Dimitrios Trafalis, Eleni Galani,George Lypas, Bülent Orhan, Sualp Tansan, Tahsin Özatlı, Onder Kırca, Okan Çakır, and George Nasioulas

Mustafa Özdoğan - Eirini Papadopoulou et al. 2021

Clinical Utility of Functional RNA Analysis for the Reclassification of Splicing Gene Variants in Hereditary Cancer

KONSTANTINOS AGIANNITOPOULOS, GEORGIA PEPE, EIRINI PAPADOPOULOU, GEORGIOS N. TSAOUSIS, STAVROULA KAMPOURI, SONIA MARAVELAKI, ATHANASSIOS FASSAS, CHRISTOS CHRISTODOULOS, RODONIKI IOSIFIDOU, SOFIA KARAGEORGOPOULOU3, CHRISTOS MARKOPOULOS, IOANNIS NATSIOPOULOS, KONSTANTINOS PAPAZISIS, MARIA VASILAKI-ANTONATOU, VASSILEIOS VENIZELOS, VAHIT OZMEN, SUALP TANSAN, KERIM KABAN, DAN TUDOR ENIU, ANGELICA CHIOREAN and GEORGE NASIOULAS

Agiannitopoulos et al 2021

Report of a germline double heterozygote in MSH2 and PALB2

Konstantinos Agiannitopoulos, Eirini Papadopoulou, Georgios N. Tsaousis, Georgia Pepe,Stavroula Kampouri, Eleni Patsea, George Lypas

Agiannitopoulos et al.2020.pdf

Clinical feasibility of NGS liquid biopsy analysis in NSCLC patients.

Eirini PapadopoulouID, Nikolaos Tsoulos, Katerina Tsantikidi, Vasiliki Metaxa- Mariatou,Pinelopi Eleftheria Stamou, Athina Kladi-Skandali, Evgenia Kapeni, Georgios Tsaousis

PDF: Papadopoulou et al 2020

Characterization of the c.793-1G > A splicing variant in CHEK2 gene as pathogenic: a case report

Konstantinos Agiannitopoulos, Eirini Papadopoulou, Georgios N. Tsaousis, Georgia Pepe, Stavroula Kampouri, Mehmet Ali Kocdor and George Nasioulas

PDF: Agiannitopoulos_et al.2019

Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.

Tsaousis G, Papadopoulou E, Apessos A, Agiannitopoulos K, Pepe G, Kampouri S, Diamantopoulos N, Floros T, Iosifidou R, Katopodi O, Koumarianou A, Markopoulos C, Papazisis K, Venizelos V, Xanthakis I, Xepapadakis G, Banu E, Eniu DT, Negru S, Stanculeanu DL, Ungureanu A, Ozmen V, Tansan S, Tekinel M, Yalcin S and Nasioulas G, BMC Cancer 2019 19:535

PDF: Tsaousis et al 2019

Comprehensive BRCA mutation analysis in the Greek population. Experience from a single clinical diagnostic center.

Apessos A, Agiannitopoulos K, Pepe G, Tsaousis GN, Papadopoulou E, Metaxa-Mariatou V, Tsirigoti A, Efstathiadou C, Markopoulos C, Xepapadakis G, Venizelos V, Tsiftsoglou A, Natsiopoulos I, Nasioulas G.
Cancer Genet. 2018 Jan;220:1-12.

PDF: Apessos A et al 2018

Tumor molecular profiling of NSCLC patients using next generation sequencing.

Tsoulos N, Papadopoulou E, Metaxa-Mariatou V, Tsaousis G, Efstathiadou C, Tounta G, Scapeti A, Bourkoula E, Zarogoulidis P, Pentheroudakis G, Kakolyris S, Boukovinas I, Papakotoulas P, Athanasiadis E, Floros T, Koumarianou A, Barbounis V, Dinischiotu A, Nasioulas G.
Oncol Rep. 2017 Dec;38(6):3419-3429.

PDF: Tsoulos et al 2017

Molecular predictive markers in tumors of the gastrointestinal tract.

Papadopoulou E, Metaxa-Mariatou V, Tsaousis G, Tsoulos N, Tsirigoti A, Efstathiadou C, Apessos A, Agiannitopoulos K, Pepe G, Bourkoula E, Nasioulas G.
World J Gastrointest Oncol. 2016 Nov 15;8(11):772-785. Review.

PDF: Papadopoulou et al 2016

Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patients.

Papadopoulou E, Tsoulos N, Tsirigoti A, Apessos A, Agiannitopoulos K, Metaxa-Mariatou V, Zarogoulidis K, Zarogoulidis P, Kasarakis D, Kakolyris S, Dahabreh J, Vlastos F, Zoublios C, Rapti A, Papageorgiou NG, Veldekis D, Gaga M, Aravantinos G, Karavasilis V, Karagiannidis N, Nasioulas G.
Oncol Lett. 2015 Oct;10(4):2176-2184.

PDF: Papadopoulou et al 2015

KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study

Negru S, Papadopoulou E, Apessos A, Stanculeanu DL, Ciuleanu E, Volovat C, Croitoru A, Kakolyris S, Aravantinos G, Ziras N, Athanasiadis E, Touroutoglou N, Pavlidis N, Kalofonos HP, Nasioulas G.
BMJ Open. 2014 May 23;4(5):e004652.

PDF: Negru et al 2014

Different genomic rearrangements account for 17% of BRCA1/2 mutations in Greece.

Angela Apessos, Eirini Papadopoulou, Vassiliki Metaxa-Mariatou, Konstantinos Agiannitopoulos et al.

Cancer Res May 1, 2015 75; P1-03-08

Meme Kanseri, Kolorektal Kanser, Tiroit Kanseri, Melanom ve Böbrek Hücreli Karsinom gibi çeşitli kalıtsal kanser tiplerinden sorumlu mutasyonların tespiti için günümüzde genetik testler yapılabilmektedir.